ReviewInternational journal of nanomedicine2025
Advanced Nanoparticle-Engineered Platforms for Peripheral Nerve Repair: Multimodal Therapeutic Strategies and Clinical Translation.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Smart-responsive electrospun scaffolds (SRES) for neural repair: Recent advances and future prospects.Bioactive materials · 2026Review
- Nanomaterial-Enhanced Conductive Hydrogels for Peripheral Nerve Repair: Biomimetic Design, Mechanisms, and Translational Challenges.International journal of nanomedicine · 2026Review
- Cellular and molecular mechanisms of thrombosis and thrombus-targeted thrombolytic strategies.Materials today. Bio · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral nerve injuries (PNIs) remain a major clinical challenge, with current surgical interventions often falling short of restoring full function. Nanoparticle (NP)-engineered platforms are emerging as transformative tools in peripheral nerve repair by enabling multimodal therapeutic delivery, spatiotemporal control of the microenvironment, and biomimetic structural support. In this review, we summarize the recent advances in the design of inorganic, polymeric, and hybrid NPs that deliver neurotrophic factors, anti-inflammatory agents, and genetic material with high precision. Functionalization strategies-ranging from conductive and piezoelectric materials to antioxidant and immunomodulatory components-enable dynamic regulation of cellular behaviors critical for regeneration. Integration of NPs into next-generation scaffolds, including smart-responsive conduits and bioactive matrices, enhances axonal guidance and Schwann cell support. We further discuss preclinical outcomes demonstrating robust functional recovery and address translational barriers, including NP toxicity, scalable fabrication, and regulatory considerations. Finally, we outline future directions involving theranostic systems and AI-guided design for personalized nerve repair. Collectively, NP-engineered systems represent a paradigm shift in peripheral nerve regeneration, offering a multifaceted approach that bridges material science, bioengineering, and clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.